Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

SCIPHERMEDICINE, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

SCIPHERMEDICINE, INC.

via HART HEALTH STRATEGIES

4th Quarter (Oct 1 - Dec 31) · 2022Posted Jan 20, 2023Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: SCIPHERMEDICINE, INC.
Description: Medical diagnostic company through gene expression
Location: Massachusetts · United States of America

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring health care regulations and legislation.
LobbyistsEMILY GRAHAM · MATTHEW DUCKWORTH · JUDITH GORSUCH
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.